Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01887678Phase 3Completed
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Traumeel / Zeel with Placebo (2 arms). Primary endpoint: Change in Knee Pain as Measured by the WOMAC Osteoarthritis Index Pain Subscale at Day 119. Started Jun 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01887678.